SPG
45
2
VTR
44
4
EQR
33
6
DVA
62
5
SNA
56
3
PPL
44
9
HOG
29
4
PEG
53
7
FAST
41
7
DD
44
2
ETN
64
4
AMG
33
-11
PSX
24
2
AMT
30
2
HBAN
47
7
SJM
17
5
PH
60
5
CVX
25
14
ADI
54
4
MHK
25
5
SPG
45
2
VTR
44
4
EQR
33
6
DVA
62
5
SNA
56
3
PPL
44
9
HOG
29
4
PEG
53
7
FAST
41
7
DD
44
2
ETN
64
4
AMG
33
-11
PSX
24
2
AMT
30
2
HBAN
47
7
SJM
17
5
PH
60
5
CVX
25
14
ADI
54
4
MHK
25
5
Financhill
Back

Editas Medicine 10K Form

Sell
22

EDIT
Editas Medicine

Last Price:
$1.33
Seasonality Move:
-11.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EDIT News And Ratings

See the #1 stock for the next 7 days that we like better than EDIT

EDIT Financial Statistics

Sales & Book Value

Annual Sales: $78.1M
Cash Flow: $-55.5M
Price / Cash Flow: 0
Annual Sales: $2.13
Price / Book: 0.62

Profitability

EPS (TTM): -2.56000
Net Income (TTM): $-210.6M
Gross Margin: --
Return on Equity: -74.59%
Return on Assets: -48.82%

Editas Medicine Earnings Forecast

Key Editas Medicine Financial Ratios

  • The Research & Development expenses have been 227.40% of Revenue.
  • The Interest Expense is 5.47% of Operating Income.
  • The Net Earning history of EDIT is -196.13% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 4 years.

Editas Medicine Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EDIT
CUSIP: 28106W
Website: editasmedicine.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.75
Quick Ratio: 3.67

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EDIT Technical Analysis vs Fundamental Analysis

Sell
22
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy or a Sell?

  • Editas Medicine stock is rated a Sell
    The current Editas Medicine [EDIT] share price is $1.31. The Score for EDIT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.